Alopexx Enterprises
Dr. Pier is a Co-Founder of Alopex. He is a Professor of Medicine, Microbiology, and Immunology at Brigham and Women’s Hospital and Harvard Medical School. Research in his laboratory led to the identification and development of the poly-N-acetyl glucosamine (PNAG) vaccine and monoclonal antibody.
This person is not in the org chart
This person is not in any offices
Alopexx Enterprises
Alopexx Enterprises works with scientists and entrepreneurs to build successful new companies. They invest in novel health care technologies at all stages of development and can serve as a lead investor or collaborate with a group of investors to advance important science. They also have the capabilities to provide management and development expertise where needed. To date, their initial investments have ranged from $1-20M.